BioVie (BIVI) Director Amy Suzon Chappell Buys 727 Shares

What Happened

• Amy Suzon Chappell, a director of BioVie Inc. (BIVI), purchased 727 shares of the company's common stock in an open-market transaction on August 28, 2026. The shares were acquired at $2.16 per share for a total reported cost of approximately $1,570. This was a purchase (insider buy), which retail investors often view as a potentially positive signal, though the dollar amount is small.

Key Details

• Transaction date: 2026-08-28
• Transaction type: Purchase (open market)
• Price per share: $2.16
• Shares acquired: 727
• Total reported value: $1,570 (approx.)
• Shares owned after transaction: Not disclosed in the provided filing
• Footnote: F1 — shares were purchased in an open market transaction
• Filing timeliness: Reported on 2026-08-28; no late filing indicated in the provided data

Context

• Small-dollar open-market buys like this show an insider adding stock, but the modest size limits how strongly it should be interpreted as a vote of confidence. There is no indication of option exercise, gift, 10b5-1 plan, or tax withholding in the filing.